Composition of the coordinating center and trial steering committee {5d}
The study team (including the PI, Co-Investigators, and project management staff) meets at least two times per month to discuss the study progress and review QA data. In addition, the study team formed an intervention change governance committee comprised of clinicians, information technology (IT) specialists, and program developers. This committee meets monthly to evaluate any requested changes to the mPATH™ program and their potential downstream effects. This committee has the final authority to determine whether a proposed change is developed, modified, or rejected.